These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15863303)
21. Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy. Davies LC; Friedlos F; Hedley D; Martin J; Ogilvie LM; Scanlon IJ; Springer CJ J Med Chem; 2005 Aug; 48(16):5321-8. PubMed ID: 16078849 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel stilbene-based antitumor agents. Simoni D; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Grisolia G; Tripathi A; Kellogg GE; Durrant D; Lee RM Bioorg Med Chem; 2009 Jan; 17(2):512-22. PubMed ID: 19117761 [TBL] [Abstract][Full Text] [Related]
23. A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier. Grinda M; Clarhaut J; Tranoy-Opalinski I; Renoux B; Monvoisin A; Cronier L; Papot S ChemMedChem; 2011 Dec; 6(12):2137-41. PubMed ID: 21815268 [No Abstract] [Full Text] [Related]
24. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides. Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs. Chen J; Du W Med Chem; 2013 Aug; 9(5):740-7. PubMed ID: 23061567 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of gibberellin derivatives with anti-tumor bioactivities. Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470 [TBL] [Abstract][Full Text] [Related]
27. Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis. Ullrich A; Chai Y; Pistorius D; Elnakady YA; Herrmann JE; Weissman KJ; Kazmaier U; Müller R Angew Chem Int Ed Engl; 2009; 48(24):4422-5. PubMed ID: 19431172 [TBL] [Abstract][Full Text] [Related]
28. Troxacitabine prodrugs for pancreatic cancer. Adema AD; Radi M; Daft J; Narayanasamy J; Hoebe EK; Alexander LE; Chu CK; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1073-7. PubMed ID: 18058539 [TBL] [Abstract][Full Text] [Related]
29. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity. Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863 [TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents. Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120 [TBL] [Abstract][Full Text] [Related]
32. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs. Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538 [TBL] [Abstract][Full Text] [Related]
33. Rapidly reversible hydrophobization: an approach to high first-pass drug extraction. Monahan SD; Subbotin VM; Budker VG; Slattum PM; Neal ZC; Herweijer H; Wolff JA Chem Biol; 2007 Sep; 14(9):1065-77. PubMed ID: 17884638 [TBL] [Abstract][Full Text] [Related]
34. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802 [TBL] [Abstract][Full Text] [Related]
36. Tuning the acyclic ether moiety of anticancer agent AA005 with conformationally constrained fragments. Liu HX; Shao F; Li GQ; Xun GL; Yao ZJ Chemistry; 2008; 14(28):8632-9. PubMed ID: 18688824 [TBL] [Abstract][Full Text] [Related]
37. Duocarmycin-based prodrugs for cancer prodrug monotherapy. Tietze LF; Schuster HJ; Schmuck K; Schuberth I; Alves F Bioorg Med Chem; 2008 Jun; 16(12):6312-8. PubMed ID: 18524605 [TBL] [Abstract][Full Text] [Related]
38. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions. Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856 [TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship studies of curcumin analogues. Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204 [TBL] [Abstract][Full Text] [Related]
40. Investigation of amino acid conjugates of (S)-1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one (DW2282) as water soluble anticancer prodrugs. Lee KC; Venkateswararao E; Sharma VK; Jung SH Eur J Med Chem; 2014 Jun; 80():439-46. PubMed ID: 24796884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]